Mizuho slashes price target on Revance Therapeutics Inc [RVNC] – find out why.
Revance Therapeutics Inc [NASDAQ: RVNC] closed the trading session at $5.26. The stocks have a year to date performance of -40.16 percent and weekly performance of -2.41 percent. The stock has been moved at 19.27 percent over the last six months. The stock has performed